Authors:
DUPUIS A
GACHARD N
ALLEGRAUD A
PRALORAN V
DENIZOT Y
Citation: A. Dupuis et al., PROSTAGLANDIN E-2 STIMULATES THE GROWTH OF HUMAN BLOOD CD34(+) PROGENITORS, PROSTAGLANDINS & OTHER LIPID MEDIATORS, 55(2-3), 1998, pp. 179-186
Citation: N. Nathan et Y. Denizot, REDUCED PAF-ACETYLHYDROLASE ACTIVITY IS ASSOCIATED WITH POSTINJURY MULTIPLE ORGAN FAILURE - PARTRICK,DAVID,A., MOORE,ERNEST,E., MOORE,FREDERICK,A., BIFFL,WALTER,L., AND BARNETT,CARLTON,C. - SHOCK-7, 170-174, 1997, Shock, 9(3), 1998, pp. 231-231
Citation: Y. Denizot et al., PLASMA LEUKEMIA INHIBITORY FACTOR, INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR LEVELS DURING CARDIOPULMONARY BYPASS WITH EXTRACORPOREAL-CIRCULATION, Cytokine, 10(4), 1998, pp. 303-306
Citation: Y. Denizot et al., EFFECTS OF LIPID MEDIATORS ON THE SYNTHESIS OF LEUKEMIA INHIBITORY FACTOR AND INTERLEUKIN-6 BY HUMAN BONE-MARROW STROMAL CELLS, Cytokine (Philadelphia, Pa. Print), 10(10), 1998, pp. 781-785
Authors:
DUPUIS F
GACHARD N
ALLEGRAUD A
DULERY C
PRALORAN V
DENIZOT Y
Citation: F. Dupuis et al., EFFECT OF PLATELET-ACTIVATING-FACTOR ON THE GROWTH OF HUMAN ERYTHROIDAND MYELOID CD34(+) PROGENITORS, Mediators of inflammation, 7(2), 1998, pp. 99-103
Citation: N. Nathan et Y. Denizot, ANTIINFLAMMATORY CYTOKINES (IL-4, IL-10, IL-13) IN PLASMA DURING MESENTERIC INFARCTION, Mediators of inflammation, 7(2), 1998, pp. 119-119
Authors:
DESPLAT V
DUPUIS F
TRIMOREAU F
DULERY C
PRALORAN V
DENIZOT Y
Citation: V. Desplat et al., EFFECTS OF LIPOXYGENASE METABOLITES OF ARACHIDONIC-ACID ON THE GROWTHOF HUMAN MONONUCLEAR MARROW-CELLS AND MARROW STROMAL CELL-CULTURES, Mediators of inflammation, 7(1), 1998, pp. 31-33
Authors:
DENIZOT Y
DULERY C
TRIMOREAU F
DESPLAT V
PRALORAN V
Citation: Y. Denizot et al., ARACHIDONIC-ACID AND HUMAN BONE-MARROW STROMAL CELLS, Biochimica et biophysica acta. Molecular cell research, 1402(2), 1998, pp. 209-215
Authors:
LORGEOT V
TRIMOREAU F
GACHARD N
PRALORAN V
DENIZOT Y
Citation: V. Lorgeot et al., LEUKEMIA INHIBITORY FACTOR CONCENTRATIONS IN THE BONE-MARROW PLASMA OF HEALTHY-SUBJECTS AND PATIENTS WITH HEMATOLOGIC MALIGNANCIES, European cytokine network, 8(1), 1997, pp. 57-59
Authors:
FIXE P
ROUGIER E
OSTYN E
GACHARD N
FAUCHER JL
PRALORAN V
DENIZOT Y
Citation: P. Fixe et al., SPONTANEOUS AND INDUCIBLE PRODUCTION OF MACROPHAGE-COLONY-STIMULATINGFACTOR BY HUMAN BONE-MARROW STOMAL CELLS, European cytokine network, 8(1), 1997, pp. 91-95
Authors:
LORGEOT V
ROUGIER F
FIXE P
CORNU E
PRALORAN V
DENIZOT Y
Citation: V. Lorgeot et al., SPONTANEOUS AND INDUCIBLE PRODUCTION OF LEUKEMIA INHIBITORY FACTOR BYHUMAN BONE-MARROW STROMAL CELLS, Cytokine, 9(10), 1997, pp. 754-758
Authors:
ROUGIER F
CORNU E
GACHARD N
PRALORAN V
DENIZOT Y
Citation: F. Rougier et al., TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) STIMULATES THE GROWTH OF HUMAN BONE-MARROW STROMAL CELLS, Mediators of inflammation, 6(3), 1997, pp. 233-235
Citation: P. Vergne et al., DECREASED LEVELS OF SERUM PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN PATIENTS WITH RHEUMATIC DISEASES, Mediators of inflammation, 6(3), 1997, pp. 241-242
Citation: N. Nathan et al., EICOSANOID AND CYTOKINE LEVELS IN PLASMA OF PATIENTS DURING MESENTERIC INFARCTION, Mediators of inflammation, 6(1), 1997, pp. 75-77
Citation: F. Dupuis et al., EFFECTS OF LIPIDIC MEDIATORS ON THE GROWTH OF HUMAN MYELOID AND ERYTHROID MARROW PROGENITORS, Journal of lipid mediators and cell signalling, 16(3), 1997, pp. 117-125
Authors:
ROUGIER F
DUPUIS F
CORNU E
DULERY C
PRALORAN V
DENIZOT Y
Citation: F. Rougier et al., PLATELET-ACTIVATING-FACTOR AND ANTAGONISTS MODULATE DNA-SYNTHESIS IN HUMAN BONE-MARROW STROMAL CELL-CULTURES, Journal of lipid mediators and cell signalling, 16(3), 1997, pp. 147-153
Authors:
DENIZOT Y
ROUGIER F
DUPUIS F
TRIMOREAU F
DULERY C
LASKAR M
PRALORAN V
Citation: Y. Denizot et al., PRESENCE AND METABOLISM OF LYSO-PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW, Journal of lipid mediators and cell signalling, 16(1), 1997, pp. 53-62
Authors:
DUPUIS F
ROUGIER F
TRIMOREAU F
OSTYN E
DULERY C
PRALORAN V
DENIZOT Y
Citation: F. Dupuis et al., PRODUCTION AND METABOLISM OF PLATELET-ACTIVATING-FACTOR BY HUMAN BONE-MARROW CELLS, Research in immunology, 148(2), 1997, pp. 119-126
Citation: V. Lorgeot et al., CONCENTRATIONS OF SERUM LEUKEMIA INHIBITORY FACTOR (LIF) IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Leukemia, 11(2), 1997, pp. 311-312
Authors:
DUPUIS F
LEVASSEUR S
JEANLOUIS F
DULERY C
PRALORAN V
DENIZOT Y
MICHEL L
Citation: F. Dupuis et al., PRODUCTION, METABOLISM AND EFFECT OF PLATELET-ACTIVATING-FACTOR ON THE GROWTH OF THE HUMAN K562 ERYTHROID CELL-LINE, Biochimica et biophysica acta. Molecular cell research, 1359(3), 1997, pp. 241-249
Authors:
TRIMOREAU F
VERGER C
PRALORAN V
DENIZOT Y
Citation: F. Trimoreau et al., NO SEX-RELATED DIFFERENCE IN THE MYELOID ERYTHROID RATIO IN MORPHOLOGICALLY NORMAL BONE-MARROW ASPIRATES/, British Journal of Haematology, 97(3), 1997, pp. 687-687
Authors:
NATHAN N
DENIZOT Y
CORNU E
JAUBERTEAU MO
CHAUVREAU C
FEISS P
Citation: N. Nathan et al., CYTOKINE AND LIPID MEDIATOR BLOOD-CONCENTRATIONS AFTER CORONARY-ARTERY SURGERY, Anesthesia and analgesia, 85(6), 1997, pp. 1240-1246
Citation: F. Rougier et al., HUMAN BONE-MARROW FIBROBLASTS - AN OVERVIEW OF THEIR CHARACTERIZATION, PROLIFERATION AND INFLAMMATORY MEDIATOR PRODUCTION, HEM CELL TH, 38(3), 1996, pp. 241-246